COVID-19 and Immunodeficiency
Corona viruses a type of virus that causes respiratory disorder such as the common cold to more acute diseases such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). Majority of people with immune deficiencies and those on immune-suppressing drugs are immune compromised, putting them at a higher risk of respiratory diseases. The most common symptomatic primary immunodeficiency in adults is common element immunodeficiency. Affected patients do not establish an adequate humoral react to community-acquired viral illnesses, and recent researches have found evidence that these patients are more susceptible to severe SARS-CoV-2 infections. The injection of COVID-19 convalescent plasma could be varying in treatment technique in this case.
- Primary immunodeficiency
- SARS-CoV-2
- COVID-19 convalescent plasma
- Genetic defects
- Covid-19 Alpha variant
- Primary immunodeficiency
- COVID-19 convalescent plasma
- SARS-CoV-2
- Genetic defects
Related Conference of COVID-19 and Immunodeficiency
5th International conference on Vaccines, Vaccination and Immunization
19th International Conference on Allergy and Clinical Immunology
5th International Conference on Immunology And Immunotherapy
COVID-19 and Immunodeficiency Conference Speakers
Recommended Sessions
- Allergy Medicine and Alternatives
- Anaphylaxis and Asthma
- Clinical Immunology and Allergy
- COVID-19 and Immunodeficiency
- Diagnostic Immunology
- Future of Food Allergy
- Immune Disorders
- Immunotherapy and Transplantation
- Immunotherapy in Cancer treatment
- Infection and Immunity
- Latest Research on Allergy Treatment
- Market and Future of Therapeutics in Immunology
- Molecular and Cellular Mechanisms of Allergic Diseases
- Neonatal and Pediatric Immunology
- Neuro Infection Treatment
- Prevention and Therapy of Allergic Diseases
- Skin Allergy and Ocular Allergy
- Types of Seasonal Allergies
- Vaccines and Immunization
- Veterinary Allergology
Related Journals
Are you interested in
- Advances in Molecular Immunology - ALLERGY 2024 (France)
- Allergen Identification and Characterization - ALLERGY 2024 (France)
- Biomarkers for Allergy Diagnosis and Treatment - ALLERGY 2024 (France)
- Case Studies in Allergy Diagnosis and Management - ALLERGY 2024 (France)
- Clinical Trials and Translational Research in Allergy and Immunology - ALLERGY 2024 (France)
- Digital Health and Telemedicine in Allergy Care - ALLERGY 2024 (France)
- Epidemiology and Population Studies in Allergic Diseases - ALLERGY 2024 (France)
- Immune Responses to Vaccination - ALLERGY 2024 (France)
- Immunogenetics and Allergic Susceptibility - ALLERGY 2024 (France)
- Immunological Aspects of Drug Allergies - ALLERGY 2024 (France)
- Immunological Basis of Food Allergy - ALLERGY 2024 (France)
- Immunological Mechanisms in Autoimmune Diseases - ALLERGY 2024 (France)
- Immunomodulation in Allergy Management - ALLERGY 2024 (France)
- Immunopathogenesis of Allergic Diseases - ALLERGY 2024 (France)
- Immunotherapy for Allergic Conditions - ALLERGY 2024 (France)
- Inflammatory Pathways in Asthma and Allergic Rhinitis - ALLERGY 2024 (France)
- Mechanisms of Immunodeficiency Diseases - ALLERGY 2024 (France)
- Novel Therapeutic Approaches for Allergic Disorders - ALLERGY 2024 (France)
- Role of Microbiota in Allergic Disorders - ALLERGY 2024 (France)